Error loading player: No playable sources found
T101e
Drug Product Continuous Manufacturing - Daurismo™ Case Study
Date
May 12, 2020
This product is not available for individual purchase, but it is available as part of the following products:
The purpose of the CMC Strategy Forum Europe 2020 is to offer a blend of topics that characterize the challenges facing the biotechnology industry in the next decade…
Continuous Manufacturing is the future standard for solid oral dosage forms. The greater process understanding, and control is redefining how drugs are produced. The faster, more precise and reliable manufacturing approach is enabling accelerated development. The case study reviews how continuous manufacturing supports accelerated development programs in a globalized context. The format will allow for interactive Q&A.
Speaker
Pfizer Pharma GmbH
Tracks
Related Products
KBI Biopharma Inc. Vendor Showcase
KBI Biopharma is a leading contract development and manufacturing organization for the biopharmaceutical industry. We accelerate and optimize drug development and manufacturing programs for our client partners…
ICH Guideline Updates and Discussion: Q12, Q13 and Q2(R2)/Q14
ICH Q12 “Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management” reached Step 4 during the last ICH meeting in Singapore in November 2019…
